Optimizing Surveillance and Re-intervention Strategy Following Elective Endovascular Repair of Abdominal Aortic Aneurysms.
Sweeting, Michael J
Rohlffs, Fiona EV
Greenhalgh, Roger M
Annals of surgery
Wolters Kluwer Health
MetadataShow full item record
Kim, L., Sweeting, M. J., Epstein, D., Venermo, M., Rohlffs, F. E., & Greenhalgh, R. M. (2019). Optimizing Surveillance and Re-intervention Strategy Following Elective Endovascular Repair of Abdominal Aortic Aneurysms.. Annals of surgery https://doi.org/10.1097/sla.0000000000003625
Background Elective endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm has an initial survival advantage over open repair (OR), but more frequent complications increase costs and long-term aneurysm-related mortality. Randomised controlled trials of EVAR versus OR have shown EVAR is not cost-effective over a patient’s lifetime. However, in the EVAR-1 trial, post-operative surveillance may have been sub-optimal, as the importance of sac growth as a predictor of graft failure was overlooked. Methods Real-world data informed a discrete event simulation model of post-operative outcomes following EVAR. Outcomes observed EVAR-1 were compared with those from five alternative post-operative surveillance and re-intervention strategies. Key events, quality-adjusted life years and costs were predicted. The impact of using complication and rupture rates from more recent devices, imaging and re-intervention methods was also explored. Results Compared with observed EVAR-1 outcomes, modelling full adherence to the EVAR-1 scan protocol reduced AAA deaths by 3% and increased elective re-interventions by 44%. European Society re-intervention guidelines provided the most clinically effective strategy, with an 8% reduction in AAA deaths, but a 52% increase in elective re-interventions. The cheapest and most cost-effective strategy used lifetime annual ultrasound in primary care with confirmatory CT if necessary, and reduced AAA-related deaths by 5%. Using contemporary rates for complications and rupture did not alter these conclusions. Conclusions All alternative strategies improved clinical benefits compared with the EVAR-1 trial. Further work is needed regarding the cost and accuracy of primary care ultrasound, and the potential impact of these strategies in the comparison with OR.
Financial support from National Institute of Health Research and Camelia Botnar Arterial Foundation. The National Institute of Health Research (NIHR) had no role in study design, data collection, data analysis, data interpretation, in the writing of the report or in the decision to submit the article for publication. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR, UK NHS, or Department of Health. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
National Institute for Health Research (NIHR) (via Imperial College London) (Unknown)
British Heart Foundation (RG/13/13/30194)
British Heart Foundation (RG/18/13/33946)
External DOI: https://doi.org/10.1097/sla.0000000000003625
This record's URL: https://www.repository.cam.ac.uk/handle/1810/296861
All rights reserved